BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25935430)

  • 1. Anaphylaxis after application of topical bacitracin-neomycin powder.
    Bommarito L; Mietta S; Cadario G
    Ann Allergy Asthma Immunol; 2015 Jul; 115(1):74-5. PubMed ID: 25935430
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin testing after anaphylaxis to a topical Neosporin preparation.
    Schroer BC; Fox CC; Hauswirth DW
    Ann Allergy Asthma Immunol; 2008 Oct; 101(4):444. PubMed ID: 18939736
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaphylaxis from topical neomycin and bacitracin.
    Goh CL
    Australas J Dermatol; 1986 Dec; 27(3):125-6. PubMed ID: 3632508
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergic nasolacrimal obstruction. Case report.
    Reifler DM
    Arch Ophthalmol; 1988 Feb; 106(2):172-3. PubMed ID: 2449155
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic foot ulcer. Identifying patient's current topical therapy aids in diagnosis.
    Levine N
    Geriatrics; 2003 Oct; 58(10):19. PubMed ID: 14569638
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of IgE antibodies to bacitracin using a commercially available streptavidin-linked solid phase in a patient with anaphylaxis to triple antibiotic ointment.
    Sharif S; Goldberg B
    Ann Allergy Asthma Immunol; 2007 Jun; 98(6):563-6. PubMed ID: 17601270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical mupirocin versus topical neosporin in the treatment of cutaneous infections.
    Wilkinson RD; Carey WD
    Int J Dermatol; 1988 Sep; 27(7):514-5. PubMed ID: 2851560
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternative for sensitizing neomycin topical medicaments.
    Fisher AA; Adams RM
    Cutis; 1981 Nov; 28(5):491, 494, 496 passim. PubMed ID: 7030646
    [No Abstract]   [Full Text] [Related]  

  • 9. Near-fatal anaphylaxis to topical bacitracin ointment.
    Lin FL; Woodmansee D; Patterson R
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):136-7. PubMed ID: 9449517
    [No Abstract]   [Full Text] [Related]  

  • 10. [Topical neomycin: risks and benefits. Plea for withdrawal].
    Assier-Bonnet H; Revuz J
    Ann Dermatol Venereol; 1997; 124(10):721-5. PubMed ID: 9740873
    [No Abstract]   [Full Text] [Related]  

  • 11. Anaphylactic shock elicited by topical administration of bacitracin.
    Roupe G; Strannegård O
    Arch Dermatol; 1969 Oct; 100(4):450-2. PubMed ID: 4187936
    [No Abstract]   [Full Text] [Related]  

  • 12. Twelve years of sensitization to neomycin in Finland. Report of 1760 cases of sensitivity to neomycin and-or bacitracin.
    Pirilä V; Förström L; Rouhunkoski S
    Acta Derm Venereol; 1967; 47(6):419-25. PubMed ID: 4168805
    [No Abstract]   [Full Text] [Related]  

  • 13. Contact urticaria syndrome and anaphylactoid reaction from topical clioquinol and bacitracin (Banocin): a case report.
    Palungwachira P
    J Med Assoc Thai; 1991 Jan; 74(1):43-6. PubMed ID: 1827491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Baneocin -- a drug of choice in prophylaxis and treatment of bacterial infections of the skin].
    Tarasenko GN; Patronov IV; Tarasenbko IuG
    Voen Med Zh; 2000 Jul; 321(7):46-7. PubMed ID: 12886537
    [No Abstract]   [Full Text] [Related]  

  • 15. Contact allergy following administration of eyedrops and eye ointments.
    Kruyswijk MR; van Driel LM; Polak BC; Go-Sennema AA
    Doc Ophthalmol; 1980 Apr; 48(2):251-3. PubMed ID: 7398524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylactic events observed within 4 h of ocular application of an antibiotic-containing ophthalmic preparation: 61 cats (1993-2010).
    Hume-Smith KM; Groth AD; Rishniw M; Walter-Grimm LA; Plunkett SJ; Maggs DJ
    J Feline Med Surg; 2011 Oct; 13(10):744-51. PubMed ID: 21906985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory evaluation of different dosage forms of baneocin for the treatment of wound infection.
    Blatun LA; Zhukov AO; Amiraslanov IuA; Terekhova RP; Agafonov VA; Askerov NG; Malina VA; Ushakov AA; Ivanov AP; Fedotov SV; Pechetov AA; Tertitskaia AB
    Khirurgiia (Mosk); 2009; (9):59-65. PubMed ID: 19824200
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic IgE-mediated hypersensitivity reaction to topical polymyxin B.
    Ngo SY; Rabbat JC
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):734-735. PubMed ID: 30053590
    [No Abstract]   [Full Text] [Related]  

  • 19. Beware of the dog: a case report on cardiac involvement in drug allergy.
    Tosoni C; Cinquini M; Gretter V; Minetti S; Rizzini FL
    J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):686-8. PubMed ID: 20671566
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of topical treatment as a determinant of infection in outpatient burns.
    Heinrich JJ; Brand DA; Cuono CB
    J Burn Care Rehabil; 1988; 9(3):253-7. PubMed ID: 2843544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.